NCT07532902 2026-04-16A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor CancerMemorial Sloan Kettering Cancer CenterPhase 1 Recruiting60 enrolled
NCT06524544 2026-04-15A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Standard of Care in the Treatment of Advanced Urothelial CancerNational Cancer Institute (NCI)Phase 3 Recruiting320 enrolled